{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-045651","form_type":"8-K","ticker":"IXHL","cik":"0001873875","company_name":"Incannex Healthcare Inc.","filed_at":"2025-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.323014+00:00","generated_at":"2026-05-21T00:30:18.996396+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Incannex cancels 50.4% of Series A Warrants, reduces potential dilution from 175M shares","bullets":["Raised $16.7M gross via ATM; used $12.5M to cancel up to 5,841,038 Series A Warrants (50.4%).","Cancellation eliminates overhang that could have caused issuance of 175.2M additional shares.","CEO Joel Latham says move puts shareholders in stronger position ahead of Phase 2 IHL-42X data.","Company plans further capital structure improvements; views this as signal of long-term value focus."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-045651","json":"https://secwatch.observer/filing/0001213900-25-045651.json","markdown":"https://secwatch.observer/filing/0001213900-25-045651.md","text":"https://secwatch.observer/filing/0001213900-25-045651.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873875/000121390025045651/0001213900-25-045651-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873875/000121390025045651/ea0242868-8k_incannex.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T00:30:18.996396+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}